• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌炎的非炎症机制:最新综述。

Myositis non-inflammatory mechanisms: An up-dated review.

作者信息

Manole Emilia, Bastian Alexandra E, Butoianu Niculina, Goebel Hans H

机构信息

a "Victor Babes" National Institute of Pathology , Bucharest , Romania.

b Research Center , Colentina Clinical Hospital , Bucharest , Romania.

出版信息

J Immunoassay Immunochem. 2017;38(2):115-126. doi: 10.1080/15321819.2017.1298525.

DOI:10.1080/15321819.2017.1298525
PMID:28375073
Abstract

Idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of rare muscular diseases, with no clearly known causes. IIM frequently have an incomplete response to treatment due to the difficulty in distinguishing between IIM forms, and due to neglect their non-inflammatory causes. Important data concerning non-immune mechanisms in IIM pathology have been recently accumulated. There is a correlation between inflammatory and non-inflammatory mechanisms, but their involvement in IIM pathogenesis is still unknown. Here we review some of the most important data regarding the non-immune IIM pathology, highlighting possible future therapeutic targets: endoplasmic reticulum stress, ATP metabolism, ROS generation, autophagy, and microRNAs disturbances.

摘要

特发性炎性肌病(IIM)是一组病因不明的罕见肌肉疾病。由于难以区分IIM的不同类型,且忽视了其非炎症性病因,IIM对治疗的反应常常不完全。最近积累了有关IIM病理学中非免疫机制的重要数据。炎症和非炎症机制之间存在关联,但其在IIM发病机制中的作用仍不清楚。在此,我们回顾一些关于IIM非免疫病理学的最重要数据,强调未来可能的治疗靶点:内质网应激、ATP代谢、活性氧生成、自噬和微小RNA紊乱。

相似文献

1
Myositis non-inflammatory mechanisms: An up-dated review.肌炎的非炎症机制:最新综述。
J Immunoassay Immunochem. 2017;38(2):115-126. doi: 10.1080/15321819.2017.1298525.
2
Nonimmune mechanisms in idiopathic inflammatory myopathies.特发性炎性肌病中的非免疫机制。
Curr Opin Rheumatol. 2020 Nov;32(6):515-522. doi: 10.1097/BOR.0000000000000748.
3
In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness?在特发性炎性肌病(IIM)中,活性氧(ROS)是否会导致肌肉无力?
Ann Rheum Dis. 2015 Jul;74(7):1340-6. doi: 10.1136/annrheumdis-2014-207172. Epub 2015 Apr 28.
4
Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies - potential role of ER stress pathways.了解特发性炎性肌病中非免疫细胞介导的肌无力的起源——内质网应激途径的潜在作用。
Curr Opin Rheumatol. 2015 Nov;27(6):580-5. doi: 10.1097/BOR.0000000000000212.
5
Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?特发性炎性肌病发病机制中的自身抗体:内质网应激反应是否发挥作用?
Front Immunol. 2022 Sep 15;13:940122. doi: 10.3389/fimmu.2022.940122. eCollection 2022.
6
Idiopathic inflammatory myopathy human derived cells retain their ability to increase mitochondrial function.特发性炎性肌病来源的人细胞保留其增强线粒体功能的能力。
PLoS One. 2020 Nov 20;15(11):e0242443. doi: 10.1371/journal.pone.0242443. eCollection 2020.
7
Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies.肌因子在肌炎发病机制中的作用及其作为特发性炎性肌病新治疗靶点的潜力。
J Immunol Res. 2020 Jul 24;2020:9079083. doi: 10.1155/2020/9079083. eCollection 2020.
8
Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies.特发性炎性肌病中肌肉损伤的非免疫机制作用。
Arthritis Res Ther. 2012 Apr 27;14(2):209. doi: 10.1186/ar3791.
9
hsa-miR-7 Is a Potential Biomarker for Idiopathic Inflammatory Myopathies with Interstitial Lung Disease in Humans.人源微小RNA-7是人类特发性炎症性肌病合并间质性肺病的潜在生物标志物。
Ann Clin Lab Sci. 2018 Nov;48(6):764-769.
10
Measurement of activation of the endoplasmic reticulum stress response in autoimmune myositis.自身免疫性肌炎中内质网应激反应激活的测量
Methods Enzymol. 2011;489:207-25. doi: 10.1016/B978-0-12-385116-1.00012-1.

引用本文的文献

1
Idiopathic Inflammatory Myopathy-Molecular Mechanisms Underlying Its Pathogenesis and Physical Therapy Effects.特发性炎性肌病——发病机制及物理治疗效果的分子机制
Int J Mol Sci. 2025 Aug 28;26(17):8369. doi: 10.3390/ijms26178369.
2
Metabolic profiling of patients with different idiopathic inflammatory myopathy subtypes reveals potential biomarkers in plasma.对不同特发性炎性肌病亚型患者的代谢组学分析揭示了血浆中的潜在生物标志物。
Clin Exp Med. 2023 Nov;23(7):3417-3429. doi: 10.1007/s10238-023-01073-6. Epub 2023 Apr 27.
3
Secondary myoadenylate deaminase deficiency is not a common feature of inflammatory myopathies: A descriptive study.
继发性肌腺苷酸脱氨酶缺乏不是炎性肌病的常见特征:一项描述性研究。
Front Med (Lausanne). 2022 Nov 23;9:1061722. doi: 10.3389/fmed.2022.1061722. eCollection 2022.
4
Cellular Stress in the Pathogenesis of Muscular Disorders-From Cause to Consequence.细胞应激在肌肉疾病发病机制中的作用——从原因到结果。
Int J Mol Sci. 2020 Aug 13;21(16):5830. doi: 10.3390/ijms21165830.
5
Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies.肌因子在肌炎发病机制中的作用及其作为特发性炎性肌病新治疗靶点的潜力。
J Immunol Res. 2020 Jul 24;2020:9079083. doi: 10.1155/2020/9079083. eCollection 2020.
6
Meta-Analysis of Polymyositis and Dermatomyositis Microarray Data Reveals Novel Genetic Biomarkers.多肌炎和皮肌炎基因芯片数据分析揭示新的遗传生物标志物
Genes (Basel). 2019 Oct 30;10(11):864. doi: 10.3390/genes10110864.
7
Current Classification and Management of Inflammatory Myopathies.当前炎症性肌病的分类和管理。
J Neuromuscul Dis. 2018;5(2):109-129. doi: 10.3233/JND-180308.
8
Risk factors and disease mechanisms in myositis.肌炎的风险因素和发病机制。
Nat Rev Rheumatol. 2018 Apr 20;14(5):255-268. doi: 10.1038/nrrheum.2018.48.
9
Update on outcome assessment in myositis.肌炎结局评估的最新进展。
Nat Rev Rheumatol. 2018 May;14(5):303-318. doi: 10.1038/nrrheum.2018.33. Epub 2018 Apr 12.